Cargando…
COVID-19 in persons with chronic myeloid leukaemia
We studied by questionnaire 530 subjects with chronic myeloid leukaemia (CML) in Hubei Province during the recent SARS-CoV-2 epidemic. Five developed confirmed (N = 4) or probable COVID-19 (N = 1). Prevalence of COVID-19 in our subjects, 0.9% (95% Confidence Interval, 0.1, 1.8%) was ninefold higher...
Autores principales: | Li, Weiming, Wang, Danyu, Guo, Jingming, Yuan, Guolin, Yang, Zhuangzhi, Gale, Robert Peter, You, Yong, Chen, Zhichao, Chen, Shiming, Wan, Chucheng, Zhu, Xiaojian, Chang, Wei, Sheng, Lingshuang, Cheng, Hui, Zhang, Youshan, Li, Qing, Qin, Jun, Meng, Li, Jiang, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233329/ https://www.ncbi.nlm.nih.gov/pubmed/32424293 http://dx.doi.org/10.1038/s41375-020-0853-6 |
Ejemplares similares
-
P666: 1 YEAR RESULTS OF DASATINIB 70MG/DAY VERSUS 100MG/DAY IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE(CML-CP):A PROSPECTIVE RANDOMIZED CONTROLLED STUDY.
por: Yu, Dan, et al.
Publicado: (2023) -
PB1960: SARS-COV-2 OMICRON VARIANT INFECTION AND COVID-19 IN PERSONS WITH CHRONIC MYELOID LEUKAEMIA IN CHINA
por: Cheng, Fang, et al.
Publicado: (2023) -
The rocky road to personalized medicine in acute myeloid leukaemia
por: Brinda, Bryan, et al.
Publicado: (2018) -
Prospects for achieving treatment‐free remission in chronic myeloid leukaemia
por: Saglio, Giuseppe, et al.
Publicado: (2020) -
Molecular techniques for the personalised management of patients with chronic myeloid leukaemia
por: Alikian, Mary, et al.
Publicado: (2017)